{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20832501", "DateCompleted": {"Year": "2011", "Month": "09", "Day": "19"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2010", "Month": "09", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1016/j.micinf.2010.09.002"], "Journal": {"ISSN": "1769-714X", "JournalIssue": {"Volume": "13", "Issue": "7", "PubDate": {"Year": "2011", "Month": "Jul"}}, "Title": "Microbes and infection", "ISOAbbreviation": "Microbes Infect"}, "ArticleTitle": "Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines.", "Pagination": {"StartPage": "613", "EndPage": "623", "MedlinePgn": "613-23"}, "Abstract": {"AbstractText": ["Buruli ulcer is a neglected disease caused by Mycobacterium ulcerans and represents the world's third most common mycobacterial infection. It produces the polyketide toxins, mycolactones A, B, C and D, which induce apoptosis and necrosis. Clinical symptoms are subcutaneous nodules, papules, plaques and ulcerating oedemae, which can enlarge and destroy nerves and blood vessels and even invade bones by lymphatic or haematogenous spread (osteomyelitis). Patients usually do not suffer from pain or systematic inflammation. Surgery is the treatment of choice, although recurrence is common and wide surgical excisions including healthy tissues result in significant morbidity. Antibiotic therapy with rifamycins, aminoglycosides, macrolides and quinolones also improves cure rates. Still less exploited treatment options are phytochemicals from medicinal plants used in affected countries. Vaccination against Buruli ulcer is still in its infancy."], "CopyrightInformation": "Copyright \u00a9 2010. Published by Elsevier SAS."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg 5, 55128 Mainz, Germany."}], "Identifier": [], "LastName": "Bamberger", "ForeName": "Denise", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jantzer", "ForeName": "Nora", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leidner", "ForeName": "Katharina", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Arend", "ForeName": "Joachim", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Microbes Infect", "NlmUniqueID": "100883508", "ISSNLinking": "1286-4579"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aminoglycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Bacterial Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Bacterial Toxins"}, {"RegistryNumber": "0", "NameOfSubstance": "Bacterial Vaccines"}, {"RegistryNumber": "0", "NameOfSubstance": "Chaperonin 60"}, {"RegistryNumber": "0", "NameOfSubstance": "Macrolides"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolones"}, {"RegistryNumber": "0", "NameOfSubstance": "Rifamycins"}, {"RegistryNumber": "0", "NameOfSubstance": "Vaccines, DNA"}, {"RegistryNumber": "0", "NameOfSubstance": "heat-shock protein 65, Mycobacterium"}, {"RegistryNumber": "0", "NameOfSubstance": "mycolactone"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Aminoglycosides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Bacterial Proteins"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Bacterial Toxins"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Bacterial Vaccines"}, {"QualifierName": ["drug therapy", "microbiology"], "DescriptorName": "Buruli Ulcer"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Chaperonin 60"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Macrolides"}, {"QualifierName": ["growth & development", "pathogenicity"], "DescriptorName": "Mycobacterium ulcerans"}, {"QualifierName": [], "DescriptorName": "Necrosis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neglected Diseases"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Quinolones"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Rifamycins"}, {"QualifierName": [], "DescriptorName": "Vaccination"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vaccines, DNA"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2010", "Month": "7", "Day": "30"}, {"Year": "2010", "Month": "9", "Day": "1"}, {"Year": "2010", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "9", "Day": "20", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20832501", "10.1016/j.micinf.2010.09.002", "S1286-4579(10)00216-9"]}}], "PubmedBookArticle": []}